Level of nitric oxide and antioxidant vitamins in sickle cell anaemia patients

Indian Journal of Physiology and Pharmacology

Volumn 56, Issue 2, 2012, Pages 125-129

  Hundekar, Prakash S ^a   Suryakar, Aadinath N ^b   Karnik, Aarti C ^a   Katkam, Raghvendra V ^c   Joshi, Nitin G ^c   Ghone, Rahul A ^a  

^a ACPM Medical College   (India)

^b MAHARASHTRA UNIVERSITY OF HEALTH SCIENCES   (India)

^c Dr V M Govt Medical College   (India)

Author keywords

Antioxidant vitamins; Nitric oxide; Oxidative stress; Sickle cell anaemia; Vasoocclussive crisis

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; NITRIC OXIDE; RETINOL;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; SICKLE CELL ANEMIA; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANTIOXIDANTS; ASCORBIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; VITAMIN A; VITAMIN E; VITAMINS;

EID: 84865368440     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Belcher JD, Marker PH, Weber JP, et al. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood 2000; 96: 2451-2459.
2. Kaul DK, Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 2000; 106: 411-420.
3. Powars D. Natural history of disease: the first two decades. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press; 1994: 395-412.
4. Katherine C, Nail-Granger D. Sickle cell Disease. Role of reactive oxygen and nitrogen metabolites. Clin and Exp Pharm and Phys 2007; 34: 926-932.
5. Neilly IJ, Copland M, Haj M, Adey G, Benjamin N, Bennett B. Plasma nitrate concentrations in neutropenic and nonneutropenic patients with suspected septicaemia. British Journal of Haematology 1995; 89: 199-202.
6. Adelekan DA, Thurnham DI, Adekile AD. Reduced antioxidant capacity in pediatric patients with homozygous sickle cell disease. Eur J of Clin Nutr 1989; 43: 609-614.
7. Das SK, Nair R. Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes. Br J Haematol 1980; 44: 87-91.
8. Najwa KC, Nabil WW. Determination of inorganic nitrate in serum and urinary by Clin Chem 1990; 36(8): 1440-1443.
9. Kimble-1938, Kaser & Stekol-1943. Varleys Practical Biochemistry, 1980, 5th edition Vol II.
10. Baker and Frank, Varleys. Practical Biochemistry, 1980, 5th edition Vol II.
11. Caraway WT. Carbohydrates N.W. Ed., Fundamentals of clinical chemistry. 2000; 173-176.
12. Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002; 8: 1383-1389.
13. Kaul DK, Liu XD, Chang HY, Nagel RL, Fabry ME. Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice. J Clin Invest 2004; 114: 1136-1145.
14. Moncada S, Higgs A. The L arginine nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
15. Eberhardt RT, McMahon L, Duffy SJ, et al. Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels. Am J Hematol 2003; 74: 104-111.
16. Nath KA, Shah V, Haggard JJ, et al. Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1949-R1955.
17. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293: 1653-1662.
18. Morris CR, Kato GJ, Polijokovic M et al. Dysregulated arginine metabolism, hemolysis associated pulmonary hypertension and mortality in sickle cell disease. JAMA 2005; 294: 81-90.
19. Aslan M, Ryan TM, Adler B, et al. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci 2001; 98: 15215-15220.
20. Aslan M, Ryan TM, Townes TM, et al. Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. J Biol Chem 2003; 278: 4194-4204.
21. Essien EU. Plasma levels of retinol, ascorbic acid and alpha-tocopherol in sickle cell anemia. Cent Afr J Med 1995; 41(2): 48-50.
22. Liu M, Wallmon A, Olsson-Mortlock C, et al. Mixed tocopherols inhibit platelet aggregation in humans: Potential mechanisms. Am J Clin Nutr 2003; 77: 700-706.
23. Ray D, Deshmukh P, Goswami K, Garg N. Antioxidant vitamin levels in sickle cell disorders. Natl Med J India 2007; 20(1): 11-13.
24. Natta CL, Machlin LJ, Brin M. A decrease in reversible sickle erythrocytes in sickle cell anaemia patients given vitamin E. Am J Clin Nutr 1980; 33: 968-971.